Literature DB >> 16357356

Monitoring device safety in interventional cardiology.

Michael E Matheny1, Lucila Ohno-Machado, Frederic S Resnic.   

Abstract

OBJECTIVE: A variety of postmarketing surveillance strategies to monitor the safety of medical devices have been supported by the U.S. Food and Drug Administration, but there are few systems to automate surveillance. Our objective was to develop a system to perform real-time monitoring of safety data using a variety of process control techniques.
DESIGN: The Web-based Data Extraction and Longitudinal Time Analysis (DELTA) system imports clinical data in real-time from an electronic database and generates alerts for potentially unsafe devices or procedures. The statistical techniques used are statistical process control (SPC), logistic regression (LR), and Bayesian updating statistics (BUS). MEASUREMENTS: We selected in-patient mortality following implantation of the Cypher drug-eluting coronary stent to evaluate our system. Data from the University of Michigan Consortium Bare-Metal Stent Study was used to calculate the event rate alerting boundaries. Data analysis was performed on local catheterization data from Brigham and Women's Hospital from July 1, 2003, shortly after the Cypher release, to December 31, 2004, including 2,270 cases with 27 observed deaths.
RESULTS: The single-stratum SPC had alerts in months 4 and 10. The multistrata SPC had alerts in months 5, 10, and 18 in the moderate-risk stratum, and months 1, 4, 7, and 10 in the high-risk stratum. The only cumulative alerts were in the first month for the high-risk stratum of the multistrata SPC. The LR method showed no monthly or cumulative alerts. The BUS method showed an alert in the first month for the high-risk stratum.
CONCLUSION: The system performed adequately within the Brigham and Women's Hospital Intranet environment based on the design goals. All three cumulative methods agreed that the overall observed event rates were not significantly higher for the new medical device than for a closely related medical device and were consistent with the observation that the initial concerns about this device dissipated as more data accumulated.

Entities:  

Mesh:

Year:  2005        PMID: 16357356      PMCID: PMC1447549          DOI: 10.1197/jamia.M1908

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  25 in total

1.  Dental device-associated problems: an analysis of FDA postmarket surveillance data.

Authors:  J Fuller; C Parmentier
Journal:  J Am Dent Assoc       Date:  2001-11       Impact factor: 3.634

2.  American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).

Authors:  C P Cannon; A Battler; R G Brindis; J L Cox; S G Ellis; N R Every; J T Flaherty; R A Harrington; H M Krumholz; M L Simoons; F J Van De Werf; W S Weintraub; K R Mitchell; S L Morrisson; R G Brindis; H V Anderson; D S Cannom; W R Chitwood; J E Cigarroa; R L Collins-Nakai; S G Ellis; R J Gibbons; F L Grover; P A Heidenreich; B K Khandheria; S B Knoebel; H L Krumholz; D J Malenka; D B Mark; C R Mckay; E R Passamani; M J Radford; R N Riner; J B Schwartz; R E Shaw; R J Shemin; D B Van Fossen; E D Verrier; M W Watkins; D R Phoubandith; T Furnelli
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

3.  Medical devices; device tracking. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2002-02-08

Review 4.  Medical device adverse events and the temporary invasive cardiac pacemaker.

Authors:  D Dwyer
Journal:  Int J Trauma Nurs       Date:  2001 Apr-Jun

5.  Standards for privacy of individually identifiable health information. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2002-08-14

6.  Postmarket surveillance. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2002-06-06

7.  Health effects associated with medical glove use.

Authors:  Sharon F Dillard; Brockton Hefflin; Ronald G Kaczmarek; Edward L Petsonk; Thomas P Gross
Journal:  AORN J       Date:  2002-07       Impact factor: 0.676

8.  Ensuring safe and effective medical devices.

Authors:  David W Feigal; Susan N Gardner; Mark McClellan
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

9.  Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions.

Authors:  M Moscucci; E Kline-Rogers; D Share; M O'Donnell; A Maxwell-Eward; W L Meengs; P Kraft; A C DeFranco; J L Chambers; K Patel; J G McGinnity; K A Eagle
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

Review 10.  An association of silicone-gel breast implant rupture and fibromyalgia.

Authors:  S Lori Brown; Hesha Jani Duggirala; Gene Pennello
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

View more
  9 in total

1.  Rare adverse event monitoring of medical devices with the use of an automated surveillance tool.

Authors:  Michael E Matheny; Nipun Arora; Lucila Ohno-Machado; Frederic S Resnic
Journal:  AMIA Annu Symp Proc       Date:  2007-10-11

2.  Development of inpatient risk stratification models of acute kidney injury for use in electronic health records.

Authors:  Michael E Matheny; Randolph A Miller; T Alp Ikizler; Lemuel R Waitman; Joshua C Denny; Jonathan S Schildcrout; Robert S Dittus; Josh F Peterson
Journal:  Med Decis Making       Date:  2010-03-30       Impact factor: 2.583

3.  An evaluation of a distributed medical device safety surveillance system: the DELTA network study.

Authors:  Venkatesan D Vidi; Michael E Matheny; Sharon Donnelly; Frederic S Resnic
Journal:  Contemp Clin Trials       Date:  2011-02-26       Impact factor: 2.226

4.  Registry-Based Prospective, Active Surveillance of Medical-Device Safety.

Authors:  Frederic S Resnic; Arjun Majithia; Danica Marinac-Dabic; Susan Robbins; Henry Ssemaganda; Kathleen Hewitt; Angelo Ponirakis; Nilsa Loyo-Berrios; Issam Moussa; Joseph Drozda; Sharon-Lise Normand; Michael E Matheny
Journal:  N Engl J Med       Date:  2017-01-25       Impact factor: 91.245

5.  Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices.

Authors:  Frederic S Resnic; Thomas P Gross; Danica Marinac-Dabic; Nilsa Loyo-Berrios; Sharon Donnelly; Sharon-Lise T Normand; Michael E Matheny
Journal:  JAMA       Date:  2010-11-10       Impact factor: 56.272

6.  Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.

Authors:  Frederic S Resnic; Arjun Majithia; Sanket S Dhruva; Henry Ssemaganda; Susan Robbins; Danica Marinac-Dabic; Kathleen Hewitt; Lucila Ohno-Machado; Matthew R Reynolds; Michael E Matheny
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-04-14

7.  The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance.

Authors:  Amit Kumar; Michael E Matheny; Kalon K L Ho; Robert W Yeh; Thomas C Piemonte; Howard Waldman; Pinak B Shah; Richard Cope; Sharon-Lise T Normand; Sharon Donnelly; Susan Robbins; Frederic S Resnic
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-12-09

8.  Validation of an automated safety surveillance system with prospective, randomized trial data.

Authors:  Michael E Matheny; David A Morrow; Lucila Ohno-Machado; Christopher P Cannon; Marc S Sabatine; Frederic S Resnic
Journal:  Med Decis Making       Date:  2008-11-17       Impact factor: 2.583

9.  Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing.

Authors:  Michael E Matheny; Sharon-Lise T Normand; Thomas P Gross; Danica Marinac-Dabic; Nilsa Loyo-Berrios; Venkatesan D Vidi; Sharon Donnelly; Frederic S Resnic
Journal:  BMC Med Inform Decis Mak       Date:  2011-12-14       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.